These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 25261710

  • 1. Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.
    Patel M, Sheng Y, Mandava NK, Pal D, Mitra AK.
    Int J Pharm; 2014 Dec 10; 476(1-2):99-107. PubMed ID: 25261710
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amino Acid Prodrugs: An Approach to Improve the Absorption of HIV-1 Protease Inhibitor, Lopinavir.
    Patel M, Mandava N, Gokulgandhi M, Pal D, Mitra AK.
    Pharmaceuticals (Basel); 2014 Apr 10; 7(4):433-52. PubMed ID: 24727459
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circumventing P-glycoprotein-mediated cellular efflux of quinidine by prodrug derivatization.
    Jain R, Majumdar S, Nashed Y, Pal D, Mitra AK.
    Mol Pharm; 2004 Apr 10; 1(4):290-9. PubMed ID: 15981588
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
    Patel J, Buddha B, Dey S, Pal D, Mitra AK.
    Am J Ther; 2004 Apr 10; 11(4):262-77. PubMed ID: 15266218
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
    Tang F, Borchardt RT.
    Pharm Res; 2002 Jun 10; 19(6):780-6. PubMed ID: 12134947
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.
    Kwatra D, Budda B, Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK.
    Mol Pharm; 2012 Jul 02; 9(7):1877-86. PubMed ID: 22676443
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor.
    Agarwal S, Pal D, Mitra AK.
    Int J Pharm; 2007 Jul 18; 339(1-2):139-47. PubMed ID: 17451894
    [Abstract] [Full Text] [Related]

  • 17. Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir.
    Wang Z, Pal D, Mitra AK.
    J Pharm Sci; 2012 Sep 18; 101(9):3199-213. PubMed ID: 22611042
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
    Eagling VA, Profit L, Back DJ.
    Br J Clin Pharmacol; 1999 Oct 18; 48(4):543-52. PubMed ID: 10583025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.